Literature DB >> 11409432

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions.

A Bitsch1, T Kuhlmann, C Stadelmann, H Lassmann, C Lucchinetti, W Brück.   

Abstract

Severe tissue destruction is the presumed histopathological correlate of hypointense multiple sclerosis (MS) lesions. In this study we correlated changes of lesion hypointensity over time with initial histopathological features in 14 biopsied MS lesions. The extent of hypointensity increased in initially demyelinated plaques and decreased in remyelinating lesions. The initial axonal loss determined the increase of hypointensity over time. In conclusion, both axonal loss and demyelinating activity determine the evolution of hypointensity over time.

Entities:  

Mesh:

Year:  2001        PMID: 11409432     DOI: 10.1002/ana.1053

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  51 in total

1.  T1 and proton density at 7 T in patients with multiple sclerosis: an initial study.

Authors:  Katharine T Bluestein; David Pitt; Michael V Knopp; Petra Schmalbrock
Journal:  Magn Reson Imaging       Date:  2011-09-19       Impact factor: 2.546

Review 2.  Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.

Authors:  Omar Khan; Rana Zabad; Christina Caon; Marina Zvartau-Hind; Alexandros Tselis; Robert Lisak
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.

Authors:  M Inglese; G Madelin; N Oesingmann; J S Babb; W Wu; B Stoeckel; J Herbert; G Johnson
Journal:  Brain       Date:  2010-01-27       Impact factor: 13.501

Review 4.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 5.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

Review 6.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

7.  Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis.

Authors:  Ales Bartos; Lenka Fialová; Jirina Soukupová; Jaromír Kukal; Ivan Malbohan; Jirí Pit'ha
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

8.  Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.

Authors:  J-M Tillema; S D Weigand; M Dayan; Y Shu; O H Kantarci; C F Lucchinetti; J D Port
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-26       Impact factor: 3.825

9.  Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.

Authors:  Belinda S Y Li; Juleiga Regal; Brian J Soher; Lois J Mannon; Robert I Grossman; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

10.  Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.

Authors:  D L Arnold; D Campagnolo; H Panitch; A Bar-Or; J Dunn; M S Freedman; S K Gazda; T Vollmer
Journal:  J Neurol       Date:  2008-10-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.